NASDAQ:COGT | Profit Breakdown | Cogent Biosciences, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2017-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$102.64M-$96.41M
2026-03-31-$103.61M-$97.35M
2025-12-31-$99.49M-$102.49M
2025-09-30-$83.36M-$80.93M
2025-06-30-$75.58M-$73.53M
2025-03-31-$74.93M-$71.99M
2024-12-31-$73.73M-$67.93M
2024-09-30-$75.41M-$70.63M
2024-06-30-$64.39M-$58.95M
2024-03-31-$62.4M-$58.35M
2023-12-31-$58.23M-$54.37M
2023-09-30-$59.58M-$55.38M
2023-06-30-$47.09M-$44.08M
2023-03-31-$43.24M-$38.59M
2022-12-31-$43.75M-$39.62M
2022-09-30-$36.82M-$35.06M
2022-06-30-$35.86M-$34.93M
2022-03-31-$31.42M-$30.63M
2021-12-31-$25.64M-$24.91M
2021-09-30-$19.82M-$19.08M
2021-06-30-$17.29M-$16.55M
2021-03-31-$12.8M-$11.73M
2020-12-31$0.00-$11.46M-$11.34M
2020-09-30$312,000.00-$57.2M-$49.98M
2020-06-30$528,000.00-$7.4M-$7.39M
2020-03-31$7.03M-$6.14M-$6.09M
2019-12-31$15.29M$2.24M$2.3M
2019-09-30$1.02M-$12.04M-$11.92M
2019-06-30$3.14M-$10.54M-$10.52M
2019-03-31$3.05M-$11.84M-$11.69M
2018-12-31$3.81M-$9M-$8.61M
2018-09-30$2.04M-$10.58M-$10.17M
2018-06-30$1.67M-$9.44M-$9.02M
2018-03-31$2.22M-$6.99M-$6.74M
2017-12-31$2.12M-$6.88M-$6.69M
2017-09-30$2.33M-$7.17M-$7M
2017-06-30$2.08M-$6.03M-$5.86M
2017-03-31-$6.07M-$5.94M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$333.36M-$328.94M
2024-12-31-$275.94M-$255.86M
2023-12-31-$208.13M-$192.41M
2022-12-31-$147.84M-$140.24M
2021-12-31-$75.55M-$72.27M
2020-12-31$7.87M-$82.2M-$74.81M
2019-12-31$22.5M-$32.18M-$31.83M
2018-12-31$9.73M-$36.01M-$34.53M
2017-12-31$8.36M-$26.15M-$25.49M